These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

48 related articles for article (PubMed ID: 23240596)

  • 21. Treatment options for residual insomnia in schizophrenia.
    Baandrup L; Jennum P; Lublin H; Glenthoj B
    Acta Psychiatr Scand; 2013 Jan; 127(1):81-2. PubMed ID: 23106614
    [No Abstract]   [Full Text] [Related]  

  • 22. [Paliperidone, risperidone].
    Takeuchi K; Sanjo K; Sakai A
    Nihon Rinsho; 2013 Apr; 71(4):654-9. PubMed ID: 23678595
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expected clinical benefits of paliperidone extended-release formulation when compared with risperidone immediate-release.
    Pani L; Marchese G
    Expert Opin Drug Deliv; 2009 Mar; 6(3):319-31. PubMed ID: 19317589
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Paliperidone extended-release tablets for the acute and maintenance treatment of schizophrenia.
    Fowler JA; Bettinger TL; Argo TR
    Clin Ther; 2008 Feb; 30(2):231-48. PubMed ID: 18343262
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Extended-release paliperidone: efficacy, safety and tolerability profile of a new atypical antipsychotic.
    Owen RT
    Drugs Today (Barc); 2007 Apr; 43(4):249-58. PubMed ID: 17460786
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Paliperidone use in the elderly.
    Madhusoodanan S; Zaveri D
    Curr Drug Saf; 2010 Apr; 5(2):149-52. PubMed ID: 20406162
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Efficacy, tolerability and safety of paliperidone extended-release in the treatment of schizophrenia and schizoaffective disorder].
    Bellantuono C; Santone G
    Riv Psichiatr; 2012; 47(1):5-20. PubMed ID: 22358213
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Practical guidelines on the use of paliperidone palmitate in schizophrenia.
    Newton R; Hustig H; Lakshmana R; Lee J; Motamarri B; Norrie P; Parker R; Schreiner A
    Curr Med Res Opin; 2012 Apr; 28(4):559-67. PubMed ID: 22321007
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Melatonin for primary insomnia?
    Drug Ther Bull; 2009 Jul; 47(7):74-7. PubMed ID: 19567841
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Paliperidone: quo vadis?
    Citrome L
    Int J Clin Pract; 2007 Apr; 61(4):653-62. PubMed ID: 17343660
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Paliperidone palmitate for schizophrenia.
    Nussbaum AM; Stroup TS
    Schizophr Bull; 2012 Nov; 38(6):1124-7. PubMed ID: 22966147
    [No Abstract]   [Full Text] [Related]  

  • 32. Paliperidone extended-release tablets: a new atypical antipsychotic.
    Howland RH
    J Psychosoc Nurs Ment Health Serv; 2007 May; 45(5):15-8. PubMed ID: 17526326
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Melatonin for children with insomnia].
    Berring-Uldum A; Debes NMM; Pedersen CR; Holst H
    Ugeskr Laeger; 2018 May; 180(19):. PubMed ID: 29761771
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Paliperidone extended release.
    Yang LP; Plosker GL
    CNS Drugs; 2007; 21(5):417-25; discussion 426-7. PubMed ID: 17447829
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Question 1. Does melatonin improve sleep pattern in children with attention deficit hyperactivity disorder?
    Snowden S
    Arch Dis Child; 2009 Apr; 94(4):321-2. PubMed ID: 19307203
    [No Abstract]   [Full Text] [Related]  

  • 36. Paliperidone extended-release for the treatment of schizophrenia.
    Marino J; Caballero J
    Pharmacotherapy; 2008 Oct; 28(10):1283-98. PubMed ID: 18823223
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Paliperidone palmitate: effectiveness, safety, and the use for treatment of schizophrenia.
    Jarema M; Bieńkowski P; Heitzman J; Parnowski T; Rybakowski J
    Psychiatr Pol; 2017 Feb; 51(1):7-21. PubMed ID: 28455891
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The use and misuse of exogenous melatonin in the treatment of sleep disorders.
    Riha RL
    Curr Opin Pulm Med; 2018 Nov; 24(6):543-548. PubMed ID: 30148726
    [TBL] [Abstract][Full Text] [Related]  

  • 39. GABA(B) receptors, schizophrenia and sleep dysfunction: a review of the relationship and its potential clinical and therapeutic implications.
    Kantrowitz J; Citrome L; Javitt D
    CNS Drugs; 2009 Aug; 23(8):681-91. PubMed ID: 19594197
    [TBL] [Abstract][Full Text] [Related]  

  • 40. European expert guidance on management of sleep onset insomnia and melatonin use in typically developing children.
    Bruni O; Breda M; Nobili L; Fietze I; Capdevila ORS; Gronfier C
    Eur J Pediatr; 2024 Jul; 183(7):2955-2964. PubMed ID: 38625388
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.